Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-011591
Filing Date
2025-08-14
Accepted
2025-08-14 17:03:40
Documents
54
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpth-20250630x10q.htm   iXBRL 10-Q 949898
2 EX-31 bpth-20250630xex31.htm EX-31 12400
3 EX-32 bpth-20250630xex32.htm EX-32 7482
  Complete submission text file 0001558370-25-011591.txt   3892494

Data Files

Seq Description Document Type Size
4 EX-101.SCH bpth-20250630.xsd EX-101.SCH 33854
5 EX-101.CAL bpth-20250630_cal.xml EX-101.CAL 34211
6 EX-101.DEF bpth-20250630_def.xml EX-101.DEF 127892
7 EX-101.LAB bpth-20250630_lab.xml EX-101.LAB 256255
8 EX-101.PRE bpth-20250630_pre.xml EX-101.PRE 221241
57 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20250630x10q_htm.xml XML 416066
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS, INC. (Filer) CIK: 0001133818 (see all company filings)

EIN.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36333 | Film No.: 251220763
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)